Study of risk factors and vision changes in keratoconus
Part of Eyes & vision clinical trials.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have keratoconus or a suspicious early form found on eye scans
- Your eye care is through CHU Montpellier, CHU Bordeaux, or CHU Toulouse
- If you’re an adult, you can sign consent after a short reflection period
- If you’re a minor, a parent or legal guardian signs consent and the child agrees after a short reflection period
- You have French social security (or are covered by it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with or at risk for keratoonus, a condition where the cornea thins and bulges. It aims to improve early detection and understand how the disease progresses.
This study looks at how people with keratoconus decide to take part in clinical research. It's for people who haven't had any treatment for keratoconus yet, and it may help improve future research studies for this condition.
This study tests whether treating donor corneal tissue with a special light and vitamin drops (called cross-linking) before a transplant helps improve outcomes for people with keratoconus. If you need a corneal transplant, this could strengthen the donor tissue and potentially reduce the need for future procedures.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This trial is for people who have keratoconus (a cornea condition that can blur vision). It involves receiving care or evaluation at the Homburg Keratoconus Center, and it may help by improving how keratoconus patients are managed.
This study looks at why keratoconus gets worse quickly in children. You may help doctors understand how collagen affects the condition.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.